תוצאות חיפוש - Sebastiano Buti

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential מאת Melissa Bersanelli, Sebastiano Buti

קבל טקסט מלא

Exploring genetic and immune underpinnings of the sexual dimorphism in tumor response to immune checkpoints inhibitors: A narrative review מאת Giulia Mazzaschi, Federico Quaini, Sebastiano Buti

קבל טקסט מלא

The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient” מאת Melissa Bersanelli, Alessio Cortellini, Sebastiano Buti

קבל טקסט מלא

Family history of cancer and DNA damage response genes: Two sides of the same coin? מאת Alessio Cortellini, Melissa Bersanelli, Corrado Ficorella, Sebastiano Buti

קבל טקסט מלא

Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trials מאת Melissa Bersanelli, Fausto Petrelli, Sebastiano Buti, Ignazio Stanganelli

קבל טקסט מלא

Systemic adjuvant therapies in renal cell carcinoma מאת Sebastiano Buti, Melissa Bersanelli, Maddalena Donini, Andrea Ardizzoni

קבל טקסט מלא

Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review מאת Melissa Bersanelli, Matteo Brunelli, Letizia Gnetti, Umberto Maestroni, Sebastiano Buti

קבל טקסט מלא

Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of “palateau” מאת Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Pasquale Rescigno, Giuseppe Luigi Banna, Sebastiano Buti

קבל טקסט מלא

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism? מאת Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, Alessia Mennitto, Carlo Messina, Chiara Airoldi, Gianmarco Vannini, Melissa Bersanelli

קבל טקסט מלא

Associations of concomitant medications with immune-related adverse events and survival in advanced cancers treated with immune checkpoint inhibitors: a comprehensive pan-cancer an... מאת Tappei Takada, Yukari Uemura, Haruki Kume, Sebastiano Buti, Satoru Taguchi, Taketo Kawai, Katsuhiko Nara, Takehito Yamamoto

קבל טקסט מלא

Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis מאת Carlo Cattrini, Carlo Messina, Chiara Airoldi, Sebastiano Buti, Giandomenico Roviello, Alessia Mennitto, Orazio Caffo, Alessandra Gennari, Melissa Bersanelli

קבל טקסט מלא

An agent-based learning model integrating sex differences in renal cell carcinoma מאת Emanuela Merelli, Tarek Taha, Marco Caputo, Destiny Obude, Edoardo Papa, Alessandro Rizzo, Sebastiano Buti, Sebastiano Buti, Francesco Massari, Francesco Massari, Javier Molina-Cerrillo, Javier Molina-Cerrillo, Fernando Sabino Marques Monteiro, Fernando Sabino Marques Monteiro, Brigida Anna Maiorano, Matteo Santoni, Matteo Santoni

קבל טקסט מלא

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors מאת Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Sebastiano Buti, Sebastiano Buti, Elisabetta Gambale, Giuseppe Procopio, Carlotta Ottanelli, Enrico Caliman, Enrico Caliman, Luca Isella, Pierangela Sepe, Nicole Brighi, Matteo Santoni, Luca Galli, Raffaele Conca, Laura Doni, Lorenzo Antonuzzo, Lorenzo Antonuzzo

קבל טקסט מלא

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors מאת Filippo G. Dall’Olio, Francesca Abbati, Francesco Facchinetti, Maria Massucci, Barbara Melotti, Anna Squadrilli, Sebastiano Buti, Francesca Formica, Marcello Tiseo, Andrea Ardizzoni

קבל טקסט מלא

Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate מאת Ondřej Fiala, Petr Hošek, Hana Korunková, Milan Hora, Jiří Kolář, Ondřej Šorejs, Ondřej Topolčan, Jan Filipovský, Václav Liška, Matteo Santoni, Sebastiano Buti, Jindřich Fínek

קבל טקסט מלא

Microplastics as both a driver of genitourinary cancers and a deliverer of treatments מאת Kannan Sridharan, Brigida Anna Maiorano, Farah Rehan, Francesca Maradonna, Elisabetta Giorgini, Tarek Taha, Javier Molina-Cerrillo, Sebastiano Buti, Francesco Piva, Francesco Massari, Matteo Santoni

קבל טקסט מלא

Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality? מאת Satoru Taguchi, Sebastiano Buti, Hiroshi Fukuhara, Masafumi Otsuka, Melissa Bersanelli, Teppei Morikawa, Hideyo Miyazaki, Tohru Nakagawa, Tetsuya Fujimura, Haruki Kume, Yasuhiko Igawa, Yukio Homma

קבל טקסט מלא

Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study מאת Sebastiano Buti, Fabiana Perrone, Teresa Zielli, Giulia Mazzaschi, Chiara Casartelli, Alessandro Leonetti, Gianluca Milanese, Mario Silva, Roberta Eufrasia Ledda, Antonino Musolino, Francesca Pucci, Melissa Bersanelli, Marcello Tiseo

קבל טקסט מלא

Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and Cryoablation מאת Lorenzo Bertolotti, Federica Segato, Francesco Pagnini, Sebastiano Buti, Andrea Casarin, Antonio Celia, Francesco Ziglioli, Umberto Maestroni, Giuseppe Pedrazzi, Velio Ascenti, Chiara Martini, Calogero Cicero, Massimo De Filippo

קבל טקסט מלא

Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma מאת Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Davide Bimbatti, Sebastiano Buti, Giulia Mazzaschi, Giuseppe Procopio, Matteo Santoni, Luca Galli, Raffaele Conca, Laura Doni, Lorenzo Antonuzzo, Giandomenico Roviello

קבל טקסט מלא